Maria Jose Serrano, Founder and Ambassador of the International Society for Liquid Biopsy, shared a post on LinkedIn:
“Excited to share our latest publication!
In this study, we show that integrating cfDNA-derived biomarkers significantly enhances the diagnostic accuracy of hepatocellular carcinoma, especially in early-stage disease, outperforming AFP and highlighting the potential of liquid biopsy for early cancer detection. Congrats Inés Aznar-Peralta!”
Title: Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis
Authors: Inés Aznar-Peralta, Amparo Roa-Colomo, Javier López Hidalgo, Cristobal Fresno, Valeria Denninghoff, María José Serrano
Other articles about CtDNA on OncoDaily.